JPRN-jRCT2080221882未知3 期
AY4166 Phase III Long-term Study in Type 2 Diabetes Patients
Ajinomoto Pharmaceuticals Co., Ltd.0 个研究点目标入组 120 人开始时间: 2012年8月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy
- •- HbA1c (NGSP) in the range of ≥ 6.9 to < 8.9 %
- •- postprandial plasma glucose 1 hour or 2hour after meal in the range of ≥ 200 mg/d
排除标准
- •- Type 1 diabetes mellitus
- •- Patients with significant complications
研究者
相似试验
已完成
不适用
An observational study on adult type 2 diabetic patients to demonstrate the utility of "Conversion of clinical information standardized in SS-MIX format to CDISC standard (ODM, CDASH, SDTM)"DiabetesJPRN-UMIN000031987Hamamatsu University School of Medicine500
招募中
不适用
Saiseikai observational study of type 2 diabetics with microangiopathy in relation to macroangiopathyType 2 diabetesJPRN-UMIN000006247SDMac Study Group200
已完成
3 期
Double blind, randomised, comparative, multicentre, parallel-group study design to evaluate the effects of Pioglitazone on cardiovascular risk markers in type 2 diabetes mellitusACTRN12608000534381Takeda Italia Farmaceutici S.p.A.100
招募中
Unknown
Korean DKD cohortEndocrine, nutritional and metabolic diseasesKCT0009635Inje University Ilsan Paik Hospital1,400
未知
Unknown
A Long-Term Clinical Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal DysfunctioType 2 Diabetes Mellitus with Renal DysfunctionJPRN-jRCT2080221504Taisho Pharmaceutical co., LTD150